NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
Back to search
Official data from USPTO
MORPHIC THERAPEUTIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MORPHIC THERAPEUTIC
ST13
US500000090790088Class
5
Filing
90790088
Registration
7724429
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/11/2025
Trademark type
Word
Nice classes
5
Filing date
06/23/2021
Registration date
03/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
03/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/02/2024
First use in commerce
07/02/2024
Drawing code
4
Owner type
03
Owner location
Waltham, MA, US
Examiner
BARREDA, AMBER KYLEE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Morphic Therapeutic, Inc.
Representatives
Bruce W. Longbottom
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and pharmaceutical preparations for use in the treatment of autoimmune and metabolic diseasesnamely inflammatory bowel disease.
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/18/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/14/2025
ALIE
ASSIGNED TO LIE
01/14/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/13/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/28/2024
GNRT
NON-FINAL ACTION E-MAILED
10/28/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/28/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/30/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/30/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/28/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/28/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/28/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/28/2024
IUAF
USE AMENDMENT FILED
07/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/30/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/29/2024
EX1G
SOU EXTENSION 1 GRANTED
02/28/2024
EXT1
SOU EXTENSION 1 FILED
02/28/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/12/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/30/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2022
GNRT
NON-FINAL ACTION E-MAILED
11/23/2022
CNRT
NON-FINAL ACTION WRITTEN
11/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/15/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/15/2022
GNRT
NON-FINAL ACTION E-MAILED
03/15/2022
CNRT
NON-FINAL ACTION WRITTEN
03/15/2022
DOCK
ASSIGNED TO EXAMINER
03/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2021
NWAP
NEW APPLICATION ENTERED
06/26/2021
Continuous trademark protection
Get notified about every new filing that threatens MORPHIC THERAPEUTIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.